Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Mining, quarrying, and oil and gas extraction tags : Disease save search
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
Published: 2024-01-03 (Crawled : 12:00) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 6.59%
H: 27.08%
C: 6.18%
disease kidney treatment
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
Published: 2023-08-29 (Crawled : 11:00) - globenewswire.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: -1.68%
H: 15.81%
C: 6.49%
drug disease kidney treat designation application
XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Polycystic Kidney Disease
Published: 2023-04-21 (Crawled : 12:00) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 4.04%
H: 3.14%
C: -6.33%
fda drug disease kidney designation
XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease
Published: 2023-04-21 (Crawled : 11:00) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 4.04%
H: 3.14%
C: -6.33%
fda drug disease kidney designation
XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
Published: 2023-02-01 (Crawled : 12:00) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 10.17%
H: 2.69%
C: -1.54%
designation drug disease kidney program xrx-008 submission
XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-12-08 (Crawled : 13:47) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.0%
C: -2.86%
disease kidney
XORTX Files New Provisional Patent to Diagnose and Treat Individuals Most at Risk of Polycystic Kidney Disease Progression
Published: 2023-01-03 (Crawled : 13:47) - xortx.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 14.52%
H: 0.0%
C: -11.37%
risk patent disease kidney
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease … – Yahoo Finance
Published: 2023-01-05 (Crawled : 14:00) - spacfeed.com
ROSE | $11.66 0.0% 3.4K
|
Miscellaneous
|
| O: -0.48%
H: 9.15%
C: 3.08%
LTUM | $0.0351 -1.96% 33.16% 410K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
fda rare disease
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance
Published: 2023-01-05 (Crawled : 13:20) - spacfeed.com
LTUM | $0.0351 -1.96% 33.16% 410K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
aum302 treatment fda rare designation disease
XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.0%
C: -2.86%
expansion disease kidney study
Polycystic Kidney Disease Drugs Market Report by Technavio predicts USD 510.69 Mn growth -- Driven by the high prevalence of chronic kidney diseases
Published: 2022-09-09 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 4.47%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -2.47%
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: -0.72%
H: 1.46%
C: -3.65%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 1.59%
H: 0.27%
C: 0.06%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: 0.0%
RGLS | $2.26 2.73% 2.22% 100K
|
Health Technology
|
| O: 3.12%
H: 3.03%
C: 1.82%
GLPG | News | $29.45 1.31% 1.36% 110K
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: -1.31%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: -0.54%
disease report kidney growth market
XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical TrialBridging Pharmacokinetics Study Part 1 Recruitment Completed for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 28.45%
H: 53.69%
C: 22.82%
oxy-101 disease kidney program
XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
Published: 2021-12-21 (Crawled : 01:00) - globenewswire.com
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.09%
H: 2.99%
C: -2.0%
patent therapeutics disease kidney
XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease• Increased Xanthine Oxidase Expression in ADPKD Kidneys •
Published: 2021-12-21 (Crawled : 13:30) - biospace.com/
XRTX | News | $2.88 -3.36% -2.41% 8.4K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.09%
H: 2.99%
C: -2.0%
patent therapeutics disease adp kidney
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.